16th International AIDS Conference


Toronto, Canada - August 13 - 18, 2006


USING MULTIPLIER METHODS TO ESTIMATE THE SIZE OF FEMALE SEX WORKER POPULATION BASED ON THE HIV/AIDS BEHAVIOURAL SURVEILLANCE SYSTEM IN TWO CHINESE CITIES

Int Conf AIDS. 2006 Aug 13-18;16 Abstract No. TuAc0405

D. Zhang1, L. Wang2, F. Lv3, P. Bi4
1 Chinese National Centre for AIDS/STD Control and Prevention, Department of Epidemiology, Beijing, China, University of Adelaide, Department of Public Health, Adelaide, Australia, 2 Chinese National Centre for AIDS/STD Control and Prevention, Department of Epidemiology, Beijing, China, 3 Chinese National Centre for AIDS /STD Control and Prevention, Department of Epidemiology, Beijing, China, 4 University of Adelaide, Department of Public Health, Adelaide, Australia


BACKGROUND: Understanding the size of the FSW population is very important for HIV/AIDS prevention and intervention. However, currently there are no standard methods to produce such estimation given their hidden and stigmatized status. This study used multiplier methods to produce estimates based on existing HIV/AIDS behavioural surveillance system (BBS) in two Chinese cities.

METHODS: Female STD attendees aged 14 years and over (except for those admitted for sexual ability reasons) were interviewed about their commercial sex behaviour in the past three months from selected STD clinics in the two Chinese cities from October to December 2003. Meanwhile, FSWs recruited from different level of entertainment establishments were interviewed about their health seeking behaviours in the above STD clinics. The size of FSW population (N) was derived by the formula N=m*p1/p2 where m is the number of female STD attendees in selected STD clinics in a given time period, p1 is the proportion of FSWs among female STD attendees in selected STD clinics, and p2 is the proportion of the FSW population who reported to have attended the selected STD clinics within the same period of time.

RESULTS: The size of the FSW population in the urban area of Xingyi was about 2,500 (842*48.9%/16.2%) with a 95% Confidence Interval of (2,000 – 3,400), which accounted for 1.4% of the total urban population. There were 17,500 FSWs in the urban area of Guiyang with a 95% CI of (10,300 – 31,900) which was 1.3% of its total urban population (rounded to the nearest 100).

CONCLUSIONS: This method is straightforward and cost-effective especially suitable to countries where HIV behavioural surveillance has been established in HIV/AIDS risk populations. Combing with HIV/AIDS behavioural surveillance system, this method could be used to generate the estimation in a broader area and indicate secular change in the FSW population size overtime.

Acrobat ReaderDownload PDF of this abstract.

2006-08-13
TuAc0405


Copyright © 2006 - International AIDS Society (IAS). All information and content relating to the abstracts from the 16th International AIDS Conference, such as text, graphics, logos, button icons, images, audio clips, and software is protected by copyright. Permission is hereby granted for the non-commercial use or reproduction of the information on this web site, provided that the use of such information is accompanied by an acknowledgement that IAS is the source of the information and the name of the author of the article.

AEGiS is a 501c(3) not-for-profit organization made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, GlaxoSmithKline, the National Library of Medicine, Roche / Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. Permission is hereby granted for the non-commercial use or reproduction of the information herein, provided that the use of such information is accompanied by an acknowledgement that IAS is the source of the information and the name of the author of the article.